comparatively small study, including people 18 and older only. the advisory panel will look. we expect data to be presented through the morning. in the afternoon, there will be a q and a. that's where there could be fireworks if the advisory panel votes to authorize this, the fda typically adopts recommendation of advisory panels but doesn't have to. a lot of suspense is built in separate from this. cdc advisers are set to meet next week to discuss the booster issue. as you know, the biden administration last month announced vaccine booster rollout would begin september 20th. that's monday. so far there's no consensus about what to do next, stephanie. >> we will be keeping a close watch on what we hear out of the fda. gabe, stay close. we have to turn to the nation's capital where law enforcement is on high alert preparing for the justice for j6